Pfizer, Inc. is an US American pharmaceutical and biotechnology company. Founded in 1849 and headquartered in New York, USA, it is a part of S&P100 and S&P500 indices. Investors can trade it under the ticker $PFE at New York Stock Exchange. Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company’s largest products by sales are the Pfizer–BioNTech COVID-19 […]

In today’s blog, we will take a look at the USDCHF Swing Sequence down from December 2016 peak and from October 2022 peak. Even when the pair has not yet broken  below January 2021 low, it already has a double incomplete sequence down from October 2022 peak and also from March 2023 peak. We will […]

3M Company (NYSE: MMM) is a globally recognized leader in innovation, manufacturing, and technology solutions. With a rich history spanning over a century, 3M has established itself as a trusted name in various industries. In this article, we will explore the Elliott Wave technical chart to provide an overview for long-term Prospects and potential opportunities that […]

Novavax, Inc. is an US American biotechnology company. Founded in 1987 and headquartered in Gaithersburg, Maryland, USA, it is a part of Russel1000 index. Investors can trade it under the ticker $NVAX at NASDAQ as well as $NVV1 at XETRA. Before 2020, the company has developed vaccines to counter such diseases like Ebola, influenza, respiratory […]

Royal Caribean has been one of the stronger symbols in the sector. The Symbol ended the Grand Super Cycle back on 01.29.2018 and did a powerful three waves back. The pullback ended on 03.13.2020, and the stock then reacted in five waves off those lows. This suggests at that moment that more upside should happen […]

Hello Traders! Today, we will look at the Daily Elliott Wave structure of AbbVie Inc. ($ABBV) and explain why the stock should soon reach a Blue Box area and react higher. AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. The company’s primary product is Humira (adalimumab) ($21 […]